Switch theme
Sign up to access all valuation multiples
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.
2004
285
Last FY Revenue $40.6M
Last FY EBITDA $10.5M
$163M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Savior Lifetec achieved revenue of $40.6M and an EBITDA of $10.5M.
Savior Lifetec expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Savior Lifetec valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $40.6M | XXX | XXX | XXX |
| Gross Profit | XXX | $11.6M | XXX | XXX | XXX |
| Gross Margin | XXX | 28% | XXX | XXX | XXX |
| EBITDA | XXX | $10.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 26% | XXX | XXX | XXX |
| EBIT | XXX | $4.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | 10% | XXX | XXX | XXX |
| Net Profit | XXX | $6.1M | XXX | XXX | XXX |
| Net Margin | XXX | 15% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Savior Lifetec's stock price is TWD 21 (or $1).
Savior Lifetec has current market cap of TWD 6.8B (or $227M), and EV of TWD 4.9B (or $163M).
See Savior Lifetec trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $163M | $227M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Savior Lifetec has market cap of $227M and EV of $163M.
Savior Lifetec's trades at 4.0x EV/Revenue multiple, and 15.5x EV/EBITDA.
Equity research analysts estimate Savior Lifetec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Savior Lifetec's P/E ratio is not available.
See valuation multiples for Savior Lifetec and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $227M | XXX | $227M | XXX | XXX | XXX |
| EV (current) | $163M | XXX | $163M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 4.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 15.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 41.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 37.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 12.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSavior Lifetec's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $27K for the same period.
Savior Lifetec's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Savior Lifetec's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Savior Lifetec and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $27K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Cohance Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Savior Lifetec acquired XXX companies to date.
Last acquisition by Savior Lifetec was XXXXXXXX, XXXXX XXXXX XXXXXX . Savior Lifetec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Savior Lifetec founded? | Savior Lifetec was founded in 2004. |
| Where is Savior Lifetec headquartered? | Savior Lifetec is headquartered in Taiwan. |
| How many employees does Savior Lifetec have? | As of today, Savior Lifetec has 285 employees. |
| Is Savior Lifetec publicy listed? | Yes, Savior Lifetec is a public company listed on ROCO. |
| What is the stock symbol of Savior Lifetec? | Savior Lifetec trades under 4167 ticker. |
| When did Savior Lifetec go public? | Savior Lifetec went public in 2015. |
| Who are competitors of Savior Lifetec? | Similar companies to Savior Lifetec include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of Savior Lifetec? | Savior Lifetec's current market cap is $227M |
| Is Savior Lifetec profitable? | Yes, Savior Lifetec is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
